nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—FDX1—ovarian follicle—ovarian cancer	0.119	0.28	CbGeAlD
Mitotane—CYP11A1—corpus luteum—ovarian cancer	0.069	0.163	CbGeAlD
Mitotane—CYP11A1—ovarian follicle—ovarian cancer	0.054	0.127	CbGeAlD
Mitotane—SERPINA6—oviduct—ovarian cancer	0.0225	0.0532	CbGeAlD
Mitotane—FDX1—uterine cervix—ovarian cancer	0.013	0.0306	CbGeAlD
Mitotane—FDX1—decidua—ovarian cancer	0.0124	0.0292	CbGeAlD
Mitotane—FDX1—endometrium—ovarian cancer	0.0118	0.0277	CbGeAlD
Mitotane—FDX1—gonad—ovarian cancer	0.0109	0.0257	CbGeAlD
Mitotane—FDX1—female reproductive system—ovarian cancer	0.00973	0.023	CbGeAlD
Mitotane—FDX1—bone marrow—ovarian cancer	0.00919	0.0217	CbGeAlD
Mitotane—FDX1—female gonad—ovarian cancer	0.00886	0.0209	CbGeAlD
Mitotane—FDX1—vagina—ovarian cancer	0.0088	0.0208	CbGeAlD
Mitotane—FDX1—testis—ovarian cancer	0.00786	0.0185	CbGeAlD
Mitotane—FDX1—lymph node—ovarian cancer	0.00569	0.0134	CbGeAlD
Mitotane—FDX1—Endogenous sterols—CYP1B1—ovarian cancer	0.00566	0.114	CbGpPWpGaD
Mitotane—CYP11A1—decidua—ovarian cancer	0.00562	0.0133	CbGeAlD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA3—ovarian cancer	0.00497	0.1	CbGpPWpGaD
Mitotane—CYP11A1—gonad—ovarian cancer	0.00495	0.0117	CbGeAlD
Mitotane—CYP11A1—female reproductive system—ovarian cancer	0.00442	0.0104	CbGeAlD
Mitotane—SHBG—endometrium—ovarian cancer	0.00428	0.0101	CbGeAlD
Mitotane—SERPINA6—female reproductive system—ovarian cancer	0.00421	0.00992	CbGeAlD
Mitotane—CYP11A1—female gonad—ovarian cancer	0.00402	0.00949	CbGeAlD
Mitotane—SERPINA6—bone marrow—ovarian cancer	0.00397	0.00936	CbGeAlD
Mitotane—SHBG—gonad—ovarian cancer	0.00397	0.00936	CbGeAlD
Mitotane—SHBG—uterus—ovarian cancer	0.00394	0.0093	CbGeAlD
Mitotane—CYP11A1—testis—ovarian cancer	0.00357	0.00842	CbGeAlD
Mitotane—SHBG—female reproductive system—ovarian cancer	0.00354	0.00836	CbGeAlD
Mitotane—SHBG—bone marrow—ovarian cancer	0.00335	0.00789	CbGeAlD
Mitotane—SHBG—female gonad—ovarian cancer	0.00322	0.0076	CbGeAlD
Mitotane—SHBG—vagina—ovarian cancer	0.00321	0.00756	CbGeAlD
Mitotane—SHBG—testis—ovarian cancer	0.00286	0.00674	CbGeAlD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00263	0.0531	CbGpPWpGaD
Mitotane—CYP11A1—lymph node—ovarian cancer	0.00259	0.0061	CbGeAlD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00213	0.043	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—CYP1B1—ovarian cancer	0.00202	0.0407	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00173	0.0348	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.00113	0.0229	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1B1—ovarian cancer	0.00113	0.0229	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.00108	0.0218	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.000937	0.0189	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000936	0.0189	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000929	0.00177	CcSEcCtD
Mitotane—Dyspepsia—Melphalan—ovarian cancer	0.000928	0.00176	CcSEcCtD
Mitotane—Haematuria—Paclitaxel—ovarian cancer	0.000926	0.00176	CcSEcCtD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000924	0.0187	CbGpPWpGaD
Mitotane—Pain—Topotecan—ovarian cancer	0.00092	0.00175	CcSEcCtD
Mitotane—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000918	0.00174	CcSEcCtD
Mitotane—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000918	0.00174	CcSEcCtD
Mitotane—Decreased appetite—Melphalan—ovarian cancer	0.000916	0.00174	CcSEcCtD
Mitotane—Infection—Vinorelbine—ovarian cancer	0.000915	0.00174	CcSEcCtD
Mitotane—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00091	0.00173	CcSEcCtD
Mitotane—Nervous system disorder—Vinorelbine—ovarian cancer	0.000903	0.00172	CcSEcCtD
Mitotane—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000901	0.00171	CcSEcCtD
Mitotane—Pain—Melphalan—ovarian cancer	0.000901	0.00171	CcSEcCtD
Mitotane—Neoplasm—Epirubicin—ovarian cancer	0.000897	0.0017	CcSEcCtD
Mitotane—Skin disorder—Vinorelbine—ovarian cancer	0.000894	0.0017	CcSEcCtD
Mitotane—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000892	0.00169	CcSEcCtD
Mitotane—Hypersensitivity—Chlorambucil—ovarian cancer	0.000891	0.00169	CcSEcCtD
Mitotane—Feeling abnormal—Topotecan—ovarian cancer	0.000887	0.00168	CcSEcCtD
Mitotane—Anorexia—Vinorelbine—ovarian cancer	0.000878	0.00167	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000873	0.0176	CbGpPWpGaD
Mitotane—Asthenia—Chlorambucil—ovarian cancer	0.000867	0.00165	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.000867	0.0175	CbGpPWpGaD
Mitotane—Neutropenia—Docetaxel—ovarian cancer	0.000863	0.00164	CcSEcCtD
Mitotane—Mental disability—Epirubicin—ovarian cancer	0.000861	0.00164	CcSEcCtD
Mitotane—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000861	0.00164	CcSEcCtD
Mitotane—Hypotension—Vinorelbine—ovarian cancer	0.00086	0.00163	CcSEcCtD
Mitotane—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000857	0.00163	CcSEcCtD
Mitotane—Urethral disorder—Paclitaxel—ovarian cancer	0.000854	0.00162	CcSEcCtD
Mitotane—Body temperature increased—Topotecan—ovarian cancer	0.000851	0.00162	CcSEcCtD
Mitotane—Visual impairment—Paclitaxel—ovarian cancer	0.00084	0.0016	CcSEcCtD
Mitotane—Neoplasm—Doxorubicin—ovarian cancer	0.00083	0.00158	CcSEcCtD
Mitotane—Diarrhoea—Chlorambucil—ovarian cancer	0.000827	0.00157	CcSEcCtD
Mitotane—Paraesthesia—Vinorelbine—ovarian cancer	0.000827	0.00157	CcSEcCtD
Mitotane—Infestation—Docetaxel—ovarian cancer	0.000823	0.00156	CcSEcCtD
Mitotane—Infestation NOS—Docetaxel—ovarian cancer	0.000823	0.00156	CcSEcCtD
Mitotane—Eye disorder—Paclitaxel—ovarian cancer	0.000815	0.00155	CcSEcCtD
Mitotane—Flushing—Paclitaxel—ovarian cancer	0.000809	0.00154	CcSEcCtD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000801	0.0162	CbGpPWpGaD
Mitotane—Decreased appetite—Vinorelbine—ovarian cancer	0.0008	0.00152	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—ovarian cancer	0.000797	0.00151	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000795	0.00151	CcSEcCtD
Mitotane—Hypersensitivity—Topotecan—ovarian cancer	0.000793	0.00151	CcSEcCtD
Mitotane—Angiopathy—Paclitaxel—ovarian cancer	0.000791	0.0015	CcSEcCtD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000791	0.016	CbGpPWpGaD
Mitotane—Pain—Vinorelbine—ovarian cancer	0.000787	0.0015	CcSEcCtD
Mitotane—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000778	0.00148	CcSEcCtD
Mitotane—Hypersensitivity—Melphalan—ovarian cancer	0.000776	0.00148	CcSEcCtD
Mitotane—Asthenia—Topotecan—ovarian cancer	0.000772	0.00147	CcSEcCtD
Mitotane—Vomiting—Chlorambucil—ovarian cancer	0.000769	0.00146	CcSEcCtD
Mitotane—SHBG—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.000765	0.0155	CbGpPWpGaD
Mitotane—Mental disorder—Paclitaxel—ovarian cancer	0.000764	0.00145	CcSEcCtD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000759	0.0153	CbGpPWpGaD
Mitotane—Malnutrition—Paclitaxel—ovarian cancer	0.000759	0.00144	CcSEcCtD
Mitotane—Feeling abnormal—Vinorelbine—ovarian cancer	0.000759	0.00144	CcSEcCtD
Mitotane—Asthenia—Melphalan—ovarian cancer	0.000756	0.00144	CcSEcCtD
Mitotane—Dysgeusia—Paclitaxel—ovarian cancer	0.000743	0.00141	CcSEcCtD
Mitotane—Hepatitis—Docetaxel—ovarian cancer	0.000739	0.0014	CcSEcCtD
Mitotane—Diarrhoea—Topotecan—ovarian cancer	0.000736	0.0014	CcSEcCtD
Mitotane—Lethargy—Epirubicin—ovarian cancer	0.000735	0.0014	CcSEcCtD
Mitotane—Urinary tract disorder—Docetaxel—ovarian cancer	0.00073	0.00139	CcSEcCtD
Mitotane—Body temperature increased—Vinorelbine—ovarian cancer	0.000728	0.00138	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—PARP1—ovarian cancer	0.000727	0.0147	CbGpPWpGaD
Mitotane—Connective tissue disorder—Docetaxel—ovarian cancer	0.000726	0.00138	CcSEcCtD
Mitotane—Urethral disorder—Docetaxel—ovarian cancer	0.000724	0.00138	CcSEcCtD
Mitotane—Diarrhoea—Melphalan—ovarian cancer	0.000721	0.00137	CcSEcCtD
Mitotane—Diplopia—Epirubicin—ovarian cancer	0.00072	0.00137	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—ovarian cancer	0.00072	0.00137	CcSEcCtD
Mitotane—Nausea—Chlorambucil—ovarian cancer	0.000718	0.00136	CcSEcCtD
Mitotane—Vision blurred—Paclitaxel—ovarian cancer	0.000715	0.00136	CcSEcCtD
Mitotane—Visual impairment—Docetaxel—ovarian cancer	0.000712	0.00135	CcSEcCtD
Mitotane—Dizziness—Topotecan—ovarian cancer	0.000712	0.00135	CcSEcCtD
Mitotane—Tremor—Paclitaxel—ovarian cancer	0.000711	0.00135	CcSEcCtD
Mitotane—Anaemia—Paclitaxel—ovarian cancer	0.000701	0.00133	CcSEcCtD
Mitotane—Eye disorder—Docetaxel—ovarian cancer	0.00069	0.00131	CcSEcCtD
Mitotane—FDX1—Metabolism—NME2—ovarian cancer	0.00069	0.0139	CbGpPWpGaD
Mitotane—Flushing—Docetaxel—ovarian cancer	0.000686	0.0013	CcSEcCtD
Mitotane—Vomiting—Topotecan—ovarian cancer	0.000684	0.0013	CcSEcCtD
Mitotane—Vertigo—Paclitaxel—ovarian cancer	0.000682	0.0013	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—ovarian cancer	0.00068	0.00129	CcSEcCtD
Mitotane—Rash—Topotecan—ovarian cancer	0.000679	0.00129	CcSEcCtD
Mitotane—Hypersensitivity—Vinorelbine—ovarian cancer	0.000678	0.00129	CcSEcCtD
Mitotane—Dermatitis—Topotecan—ovarian cancer	0.000678	0.00129	CcSEcCtD
Mitotane—Ataxia—Epirubicin—ovarian cancer	0.000677	0.00129	CcSEcCtD
Mitotane—Headache—Topotecan—ovarian cancer	0.000674	0.00128	CcSEcCtD
Mitotane—Angiopathy—Docetaxel—ovarian cancer	0.00067	0.00127	CcSEcCtD
Mitotane—Vomiting—Melphalan—ovarian cancer	0.00067	0.00127	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—ovarian cancer	0.000667	0.00127	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—ovarian cancer	0.000667	0.00127	CcSEcCtD
Mitotane—Rash—Melphalan—ovarian cancer	0.000664	0.00126	CcSEcCtD
Mitotane—Dermatitis—Melphalan—ovarian cancer	0.000664	0.00126	CcSEcCtD
Mitotane—Asthenia—Vinorelbine—ovarian cancer	0.000661	0.00125	CcSEcCtD
Mitotane—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000658	0.00125	CcSEcCtD
Mitotane—Hypertension—Paclitaxel—ovarian cancer	0.000655	0.00124	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—ovarian cancer	0.000651	0.00124	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000649	0.0131	CbGpPWpGaD
Mitotane—Mental disorder—Docetaxel—ovarian cancer	0.000647	0.00123	CcSEcCtD
Mitotane—Malnutrition—Docetaxel—ovarian cancer	0.000643	0.00122	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000642	0.00122	CcSEcCtD
Mitotane—Nausea—Topotecan—ovarian cancer	0.000639	0.00121	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—ovarian cancer	0.000635	0.00121	CcSEcCtD
Mitotane—Diarrhoea—Vinorelbine—ovarian cancer	0.00063	0.0012	CcSEcCtD
Mitotane—Dysgeusia—Docetaxel—ovarian cancer	0.00063	0.0012	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—ovarian cancer	0.000627	0.00119	CcSEcCtD
Mitotane—Nausea—Melphalan—ovarian cancer	0.000626	0.00119	CcSEcCtD
Mitotane—Confusional state—Paclitaxel—ovarian cancer	0.000624	0.00119	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—PARP1—ovarian cancer	0.000622	0.0126	CbGpPWpGaD
Mitotane—Infection—Paclitaxel—ovarian cancer	0.000615	0.00117	CcSEcCtD
Mitotane—Shock—Paclitaxel—ovarian cancer	0.000609	0.00116	CcSEcCtD
Mitotane—Dizziness—Vinorelbine—ovarian cancer	0.000609	0.00116	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000609	0.00116	CcSEcCtD
Mitotane—Nervous system disorder—Paclitaxel—ovarian cancer	0.000607	0.00115	CcSEcCtD
Mitotane—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000606	0.00115	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—ovarian cancer	0.000602	0.00114	CcSEcCtD
Mitotane—Skin disorder—Paclitaxel—ovarian cancer	0.000602	0.00114	CcSEcCtD
Mitotane—Anaemia—Docetaxel—ovarian cancer	0.000594	0.00113	CcSEcCtD
Mitotane—Anorexia—Paclitaxel—ovarian cancer	0.00059	0.00112	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—ovarian cancer	0.000588	0.00112	CcSEcCtD
Mitotane—Vomiting—Vinorelbine—ovarian cancer	0.000585	0.00111	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000585	0.0118	CbGpPWpGaD
Mitotane—Neutropenia—Epirubicin—ovarian cancer	0.000582	0.00111	CcSEcCtD
Mitotane—Rash—Vinorelbine—ovarian cancer	0.000581	0.0011	CcSEcCtD
Mitotane—Dermatitis—Vinorelbine—ovarian cancer	0.00058	0.0011	CcSEcCtD
Mitotane—Hypotension—Paclitaxel—ovarian cancer	0.000579	0.0011	CcSEcCtD
Mitotane—Headache—Vinorelbine—ovarian cancer	0.000577	0.0011	CcSEcCtD
Mitotane—Paraesthesia—Paclitaxel—ovarian cancer	0.000556	0.00106	CcSEcCtD
Mitotane—Hypertension—Docetaxel—ovarian cancer	0.000555	0.00105	CcSEcCtD
Mitotane—Infestation—Epirubicin—ovarian cancer	0.000555	0.00105	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—ovarian cancer	0.000555	0.00105	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—ovarian cancer	0.000555	0.00105	CcSEcCtD
Mitotane—Somnolence—Paclitaxel—ovarian cancer	0.000551	0.00105	CcSEcCtD
Mitotane—Nausea—Vinorelbine—ovarian cancer	0.000547	0.00104	CcSEcCtD
Mitotane—Dyspepsia—Paclitaxel—ovarian cancer	0.000545	0.00104	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000544	0.00103	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—ovarian cancer	0.000539	0.00102	CcSEcCtD
Mitotane—Decreased appetite—Paclitaxel—ovarian cancer	0.000538	0.00102	CcSEcCtD
Mitotane—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000535	0.00102	CcSEcCtD
Mitotane—Pain—Paclitaxel—ovarian cancer	0.00053	0.00101	CcSEcCtD
Mitotane—Haematuria—Epirubicin—ovarian cancer	0.000529	0.00101	CcSEcCtD
Mitotane—Confusional state—Docetaxel—ovarian cancer	0.000529	0.00101	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000525	0.000997	CcSEcCtD
Mitotane—Infection—Docetaxel—ovarian cancer	0.000521	0.000991	CcSEcCtD
Mitotane—Shock—Docetaxel—ovarian cancer	0.000516	0.000981	CcSEcCtD
Mitotane—Nervous system disorder—Docetaxel—ovarian cancer	0.000515	0.000978	CcSEcCtD
Mitotane—Thrombocytopenia—Docetaxel—ovarian cancer	0.000514	0.000976	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—ovarian cancer	0.000514	0.000976	CcSEcCtD
Mitotane—Infestation—Doxorubicin—ovarian cancer	0.000514	0.000976	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—ovarian cancer	0.000514	0.000976	CcSEcCtD
Mitotane—Feeling abnormal—Paclitaxel—ovarian cancer	0.00051	0.000969	CcSEcCtD
Mitotane—Skin disorder—Docetaxel—ovarian cancer	0.00051	0.000969	CcSEcCtD
Mitotane—Anorexia—Docetaxel—ovarian cancer	0.0005	0.000951	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—ovarian cancer	0.000498	0.000947	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—ovarian cancer	0.000492	0.000935	CcSEcCtD
Mitotane—Hypotension—Docetaxel—ovarian cancer	0.00049	0.000932	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—ovarian cancer	0.00049	0.00093	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—ovarian cancer	0.00049	0.00093	CcSEcCtD
Mitotane—Body temperature increased—Paclitaxel—ovarian cancer	0.00049	0.00093	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—ovarian cancer	0.000488	0.000928	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000486	0.000923	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—ovarian cancer	0.00048	0.000912	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000477	0.00964	CbGpPWpGaD
Mitotane—Paraesthesia—Docetaxel—ovarian cancer	0.000471	0.000895	CcSEcCtD
Mitotane—Somnolence—Docetaxel—ovarian cancer	0.000467	0.000886	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—ovarian cancer	0.000466	0.000885	CcSEcCtD
Mitotane—Flushing—Epirubicin—ovarian cancer	0.000462	0.000879	CcSEcCtD
Mitotane—Dyspepsia—Docetaxel—ovarian cancer	0.000462	0.000878	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—ovarian cancer	0.000461	0.000876	CcSEcCtD
Mitotane—Decreased appetite—Docetaxel—ovarian cancer	0.000456	0.000867	CcSEcCtD
Mitotane—Hypersensitivity—Paclitaxel—ovarian cancer	0.000456	0.000867	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000455	0.000865	CcSEcCtD
Mitotane—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000453	0.000861	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000453	0.000861	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—ovarian cancer	0.000452	0.000859	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—ovarian cancer	0.000452	0.000859	CcSEcCtD
Mitotane—Pain—Docetaxel—ovarian cancer	0.000449	0.000853	CcSEcCtD
Mitotane—FDX1—Metabolism—CYTB—ovarian cancer	0.000445	0.00898	CbGpPWpGaD
Mitotane—Visual impairment—Doxorubicin—ovarian cancer	0.000444	0.000844	CcSEcCtD
Mitotane—Asthenia—Paclitaxel—ovarian cancer	0.000444	0.000844	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—ovarian cancer	0.000437	0.000829	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000435	0.00878	CbGpPWpGaD
Mitotane—Malnutrition—Epirubicin—ovarian cancer	0.000434	0.000824	CcSEcCtD
Mitotane—Feeling abnormal—Docetaxel—ovarian cancer	0.000433	0.000822	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—ovarian cancer	0.000431	0.000819	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TLR4—ovarian cancer	0.000429	0.00866	CbGpPWpGaD
Mitotane—Flushing—Doxorubicin—ovarian cancer	0.000428	0.000813	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—ovarian cancer	0.000425	0.000807	CcSEcCtD
Mitotane—Diarrhoea—Paclitaxel—ovarian cancer	0.000424	0.000805	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—ovarian cancer	0.000418	0.000795	CcSEcCtD
Mitotane—Body temperature increased—Docetaxel—ovarian cancer	0.000415	0.000788	CcSEcCtD
Mitotane—Dizziness—Paclitaxel—ovarian cancer	0.00041	0.000778	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—ovarian cancer	0.000409	0.000777	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—ovarian cancer	0.000404	0.000767	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP1B1—ovarian cancer	0.000403	0.00815	CbGpPWpGaD
Mitotane—Malnutrition—Doxorubicin—ovarian cancer	0.000401	0.000763	CcSEcCtD
Mitotane—Anaemia—Epirubicin—ovarian cancer	0.000401	0.000762	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000398	0.00803	CbGpPWpGaD
Mitotane—Vomiting—Paclitaxel—ovarian cancer	0.000394	0.000748	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—ovarian cancer	0.000393	0.000747	CcSEcCtD
Mitotane—Rash—Paclitaxel—ovarian cancer	0.00039	0.000742	CcSEcCtD
Mitotane—Dermatitis—Paclitaxel—ovarian cancer	0.00039	0.000741	CcSEcCtD
Mitotane—Vertigo—Epirubicin—ovarian cancer	0.00039	0.00074	CcSEcCtD
Mitotane—FDX1—Metabolism—BRIP1—ovarian cancer	0.000389	0.00785	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPP1CC—ovarian cancer	0.000389	0.00785	CbGpPWpGaD
Mitotane—Headache—Paclitaxel—ovarian cancer	0.000388	0.000737	CcSEcCtD
Mitotane—Hypersensitivity—Docetaxel—ovarian cancer	0.000387	0.000735	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—ovarian cancer	0.000378	0.000719	CcSEcCtD
Mitotane—Asthenia—Docetaxel—ovarian cancer	0.000377	0.000715	CcSEcCtD
Mitotane—Hypertension—Epirubicin—ovarian cancer	0.000375	0.000712	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—ovarian cancer	0.000371	0.000705	CcSEcCtD
Mitotane—Nausea—Paclitaxel—ovarian cancer	0.000368	0.000699	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000367	0.000697	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TLR4—ovarian cancer	0.000367	0.00741	CbGpPWpGaD
Mitotane—Vertigo—Doxorubicin—ovarian cancer	0.000361	0.000685	CcSEcCtD
Mitotane—Diarrhoea—Docetaxel—ovarian cancer	0.000359	0.000682	CcSEcCtD
Mitotane—Confusional state—Epirubicin—ovarian cancer	0.000357	0.000678	CcSEcCtD
Mitotane—Infection—Epirubicin—ovarian cancer	0.000352	0.000668	CcSEcCtD
Mitotane—Shock—Epirubicin—ovarian cancer	0.000348	0.000662	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—ovarian cancer	0.000347	0.00066	CcSEcCtD
Mitotane—Dizziness—Docetaxel—ovarian cancer	0.000347	0.000659	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—ovarian cancer	0.000347	0.000659	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—ovarian cancer	0.000347	0.000658	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1B1—ovarian cancer	0.000345	0.00697	CbGpPWpGaD
Mitotane—Skin disorder—Epirubicin—ovarian cancer	0.000344	0.000653	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00034	0.00687	CbGpPWpGaD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000339	0.000645	CcSEcCtD
Mitotane—Anorexia—Epirubicin—ovarian cancer	0.000337	0.000641	CcSEcCtD
Mitotane—Vomiting—Docetaxel—ovarian cancer	0.000334	0.000634	CcSEcCtD
Mitotane—Rash—Docetaxel—ovarian cancer	0.000331	0.000629	CcSEcCtD
Mitotane—Hypotension—Epirubicin—ovarian cancer	0.000331	0.000628	CcSEcCtD
Mitotane—Dermatitis—Docetaxel—ovarian cancer	0.000331	0.000628	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—ovarian cancer	0.00033	0.000628	CcSEcCtD
Mitotane—Headache—Docetaxel—ovarian cancer	0.000329	0.000625	CcSEcCtD
Mitotane—Infection—Doxorubicin—ovarian cancer	0.000325	0.000618	CcSEcCtD
Mitotane—Shock—Doxorubicin—ovarian cancer	0.000322	0.000612	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—ovarian cancer	0.000321	0.00061	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000321	0.000609	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—ovarian cancer	0.000318	0.000604	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—ovarian cancer	0.000318	0.000604	CcSEcCtD
Mitotane—Somnolence—Epirubicin—ovarian cancer	0.000315	0.000598	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—ovarian cancer	0.000312	0.000593	CcSEcCtD
Mitotane—Nausea—Docetaxel—ovarian cancer	0.000312	0.000592	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—ovarian cancer	0.000312	0.000592	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000311	0.00628	CbGpPWpGaD
Mitotane—Decreased appetite—Epirubicin—ovarian cancer	0.000308	0.000585	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—ovarian cancer	0.000306	0.000582	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000306	0.000581	CcSEcCtD
Mitotane—Pain—Epirubicin—ovarian cancer	0.000303	0.000575	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—ovarian cancer	0.000294	0.000559	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—ovarian cancer	0.000292	0.000554	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—ovarian cancer	0.000291	0.000553	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CXCL8—ovarian cancer	0.000291	0.00587	CbGpPWpGaD
Mitotane—Dyspepsia—Doxorubicin—ovarian cancer	0.000288	0.000548	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—ovarian cancer	0.000285	0.000541	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000283	0.00572	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000283	0.000537	CcSEcCtD
Mitotane—Pain—Doxorubicin—ovarian cancer	0.00028	0.000532	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—ovarian cancer	0.00028	0.000532	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—ovarian cancer	0.000278	0.00562	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL2—ovarian cancer	0.000278	0.00561	CbGpPWpGaD
Mitotane—Feeling abnormal—Doxorubicin—ovarian cancer	0.00027	0.000513	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CTNNB1—ovarian cancer	0.000268	0.00542	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000266	0.00537	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—ovarian cancer	0.000261	0.000496	CcSEcCtD
Mitotane—FDX1—Metabolism—YAP1—ovarian cancer	0.000261	0.00527	CbGpPWpGaD
Mitotane—Body temperature increased—Doxorubicin—ovarian cancer	0.000259	0.000492	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000258	0.00521	CbGpPWpGaD
Mitotane—Asthenia—Epirubicin—ovarian cancer	0.000254	0.000483	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CXCL8—ovarian cancer	0.000249	0.00502	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NME2—ovarian cancer	0.000246	0.00497	CbGpPWpGaD
Mitotane—Diarrhoea—Epirubicin—ovarian cancer	0.000242	0.00046	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—ovarian cancer	0.000241	0.000459	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—ovarian cancer	0.000238	0.00481	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL2—ovarian cancer	0.000238	0.0048	CbGpPWpGaD
Mitotane—Asthenia—Doxorubicin—ovarian cancer	0.000235	0.000447	CcSEcCtD
Mitotane—Dizziness—Epirubicin—ovarian cancer	0.000234	0.000445	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CTNNB1—ovarian cancer	0.000229	0.00464	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000227	0.00458	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—ovarian cancer	0.000225	0.000428	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—ovarian cancer	0.000224	0.000426	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK3—ovarian cancer	0.000223	0.00451	CbGpPWpGaD
Mitotane—Rash—Epirubicin—ovarian cancer	0.000223	0.000424	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—ovarian cancer	0.000223	0.000424	CcSEcCtD
Mitotane—Headache—Epirubicin—ovarian cancer	0.000222	0.000421	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—ovarian cancer	0.000217	0.000412	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK1—ovarian cancer	0.000213	0.00429	CbGpPWpGaD
Mitotane—FDX1—Metabolism—FASN—ovarian cancer	0.000213	0.00429	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NME2—ovarian cancer	0.00021	0.00425	CbGpPWpGaD
Mitotane—Nausea—Epirubicin—ovarian cancer	0.00021	0.0004	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC5A5—ovarian cancer	0.000209	0.00422	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000209	0.00421	CbGpPWpGaD
Mitotane—Vomiting—Doxorubicin—ovarian cancer	0.000208	0.000396	CcSEcCtD
Mitotane—Rash—Doxorubicin—ovarian cancer	0.000207	0.000392	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—ovarian cancer	0.000206	0.000392	CcSEcCtD
Mitotane—Headache—Doxorubicin—ovarian cancer	0.000205	0.00039	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC2A1—ovarian cancer	0.000202	0.00408	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000198	0.00399	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—ovarian cancer	0.000195	0.00037	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP1B1—ovarian cancer	0.000194	0.00391	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK3—ovarian cancer	0.000191	0.00386	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK1—ovarian cancer	0.000182	0.00367	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000178	0.0036	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPP2R1A—ovarian cancer	0.000172	0.00347	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000171	0.00345	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00017	0.00343	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCB1—ovarian cancer	0.000159	0.00322	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYTB—ovarian cancer	0.000158	0.0032	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TYMS—ovarian cancer	0.000157	0.00316	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000155	0.00313	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—ovarian cancer	0.000151	0.00304	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000145	0.00294	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPP1CC—ovarian cancer	0.000138	0.0028	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BRIP1—ovarian cancer	0.000138	0.0028	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYTB—ovarian cancer	0.000136	0.00274	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000132	0.00268	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—ovarian cancer	0.000129	0.0026	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CAV1—ovarian cancer	0.000126	0.00255	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000121	0.00243	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BRIP1—ovarian cancer	0.000118	0.00239	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPP1CC—ovarian cancer	0.000118	0.00239	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CG—ovarian cancer	0.000115	0.00232	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CD—ovarian cancer	0.000101	0.00204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000101	0.00204	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—YAP1—ovarian cancer	9.29e-05	0.00188	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.19e-05	0.00186	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CB—ovarian cancer	8.8e-05	0.00178	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.63e-05	0.00174	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.08e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—YAP1—ovarian cancer	7.95e-05	0.00161	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.86e-05	0.00159	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTEN—ovarian cancer	7.61e-05	0.00154	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—FASN—ovarian cancer	7.57e-05	0.00153	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC5A5—ovarian cancer	7.45e-05	0.0015	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A1—ovarian cancer	7.19e-05	0.00145	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.04e-05	0.00142	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.91e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1B1—ovarian cancer	6.9e-05	0.00139	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FASN—ovarian cancer	6.48e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC5A5—ovarian cancer	6.37e-05	0.00129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A1—ovarian cancer	6.15e-05	0.00124	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPP2R1A—ovarian cancer	6.12e-05	0.00124	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.09e-05	0.00123	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.03e-05	0.00122	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1B1—ovarian cancer	5.9e-05	0.00119	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCB1—ovarian cancer	5.68e-05	0.00115	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TYMS—ovarian cancer	5.58e-05	0.00113	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CA—ovarian cancer	5.37e-05	0.00108	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPP2R1A—ovarian cancer	5.23e-05	0.00106	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.21e-05	0.00105	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—ovarian cancer	4.86e-05	0.000981	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TYMS—ovarian cancer	4.77e-05	0.000964	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAV1—ovarian cancer	4.49e-05	0.000908	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—ovarian cancer	4.38e-05	0.000886	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.29e-05	0.000867	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CG—ovarian cancer	4.09e-05	0.000827	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAV1—ovarian cancer	3.84e-05	0.000777	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.67e-05	0.000742	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CD—ovarian cancer	3.6e-05	0.000727	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CG—ovarian cancer	3.5e-05	0.000707	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CB—ovarian cancer	3.14e-05	0.000634	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CD—ovarian cancer	3.08e-05	0.000622	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTEN—ovarian cancer	2.71e-05	0.000548	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CB—ovarian cancer	2.68e-05	0.000542	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTEN—ovarian cancer	2.32e-05	0.000468	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—ovarian cancer	1.91e-05	0.000386	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—ovarian cancer	1.64e-05	0.00033	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—ovarian cancer	1.56e-05	0.000316	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—ovarian cancer	1.34e-05	0.00027	CbGpPWpGaD
